Cortechs.ai | Cortechs.ai and Hitachi announce support of Hitachi MRI scanners for NeuroQuant®

Cortechs.ai and Hitachi announce support of Hitachi MRI scanners for NeuroQuant®

Increased Physician Access to Volumetric MRI Processing with Additional Scanner Options, Including Open MRIs

(SAN DIEGO) – Cortechs.ai, the leading medical software innovator providing solutions for quantitative brain volume analysis, is pleased to announce that Hitachi 1.2T Oasis, 1.5T Echelon Oval and 3.0T Trillium Oval MRI scanners are compatible with NeuroQuant®, the foremost medical device software for volumetric MRI processing. Cortechs.ai and Hitachi worked together to validate the 1.2T, 1.5T and 3.0T Hitachi MRI scanners, ensuring accurate and consistent brain segmentation results for Hitachi MRI customers.

This capability provides neuroradiologists in hospitals, clinics, imaging and research centers worldwide with expanded MRI scanner options when using Cortechs.ai automated brain image analysis software solutions in the assessment of neurodegeneration disorders, such as Alzheimer’s disease, epilepsy, multiple sclerosis, as well as, brain volume changes caused by brain trauma.

Cortechs.ai’ fast, accurate, reproducible, and proven quantitative imaging solution is the first FDA cleared and CE marked software that provides radiologists and neurologists with quantifiable, volumetric data to help in the assessment of brain atrophy and lesion evolution.

“This Hitachi scanner validation marks the first time that NeuroQuant products can be used with open MRI scanners, helping to accommodate a broader patient demographic for neurodegenerative evaluations,” said Guri Stark, Cortechs.ai’ CEO. “We are excited to include Hitachi 1.2T, 1.5T and 3.0T MRI scanners as options for NeuroQuant analysis, thereby strengthening our goal of providing a vendor neutral product, allowing physicians and clinicians more freedom in MRI scanner choices.”

“We are always looking to provide our customers with enhanced and expanded imaging capabilities,” said Sheldon Schaffer, Vice President and General Manager, MR/CT, Hitachi Healthcare Americas. “With NeuroQuant products now validated and compatible with Hitachi 1.2T Oasis, 1.5T Echelon Oval and 3.0T Trillium Oval MRI scanners, healthcare providers have access to exceptional automated brain volume imaging technology, allowing them to deliver better patient care in Hitachi’s unique patient-centric environment.”

ABOUT CORTECHS LABS
Cortechs.ai develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice. Cortechs.ai’ cutting-edge brain imaging analysis provides neurologists, radiologists, and clinical researchers worldwide with a convenient and cost-effective means to quantify subcortical structures to help assess a variety of neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma and brain development. Please visit cortechs.ai for further information.

ABOUT HITACHI HEALTHCARE AMERICAS
Hitachi Healthcare Americas, located in Twinsburg, Ohio, a wholly owned subsidiary of Hitachi Healthcare Business Unit, offers a broad range of diagnostic imaging equipment including MRI, CT and Ultrasound. Hitachi’s MRI, CT and Ultrasound technologies provide speed, comfort and quality for both physicians and patients alike and play an important role in the diagnosis and treatment of disease while driving social innovation into healthcare. Visit www.hitachihealthcare.com.

ABOUT HITACHI, LTD.
Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges. The company’s consolidated revenues for fiscal 2016 (ended March 31, 2017) totaled 9,162.2 billion yen ($81.8 billion). The Hitachi Group is a global leader in the Social Innovation Business, and it has approximately 304,000 employees worldwide. Through collaborative creation, Hitachi is providing solutions to customers in a broad range of sectors, including Power / Energy, Industry / Distribution / Water, Urban Development, and Finance / Government & Public / Healthcare. For more information on Hitachi, please visit the company’s website at www.hitachi.com

More Resources

05/11/2026

Better Models, Better Care: Inside Our Latest Brain Tumor Update

Explore how NeuroQuant® Brain Tumor v2.1 advances AI-powered brain tumor segmentation and clinical workflows.

05/05/2026

The American Academy of Neurology: Shaping the Future of Neurologic Care 

AI-driven clinical quantification is becoming standard in neurologic care

04/27/2026

Deep Learning Reconstruction and Quantitative MRI: Advancing Imaging Without Compromising Consistency

Deep learning reconstruction enhances MRI speed and clarity while preserving the consistency and reliability of quantitative imaging

04/10/2026

OnQ Prostate Vendor Validation: From Research to Clinical Adoption

OnQ Prostate delivers consistent, reliable AI-powered prostate MRI insights across vendors, ensuring confident diagnosis and streamlined clinical workflows.

03/20/2026

Quantitative MRI, the McDonald Criteria, and the Future of Multiple Sclerosis Care

MRI is the foundation for diagnosing and monitoring multiple sclerosis (MS)

03/13/2026

Cortechs Cares: Community Impact and Volunteer Efforts in 2025

Cortechs Cares highlights how our team gave back in 2025 through community volunteer efforts, including an Alzheimer’s Walk and holiday toy drive.
Scroll to Top